The expansion of telehealth platforms into men’s health — testosterone replacement therapy, erectile dysfunction treatment, GLP-1 weight management, and online GP consultations — has created genuine convenience for patients and genuine complexity for consumers trying to evaluate their options.
Which platforms offer legitimate clinical governance? Which are transparent about pricing? Which actually serve UK-based patients, and which are US-only services with misleading “international” branding? These are the questions this section is designed to answer.
What We Cover
TRT Platforms: Online clinics and telehealth services offering testosterone replacement therapy consultations, blood testing, and prescription management. We evaluate the clinical model (who is prescribing, under what regulatory framework), pricing transparency, UK availability, and whether the platform’s marketing accurately represents what the service delivers.
ED Treatment Platforms: Digital health services offering erectile dysfunction consultations and prescription treatments. We assess whether these platforms provide genuine clinical evaluation or function primarily as prescription fulfilment services with minimal clinical oversight. For UK readers, we note whether the prescriber operates under CQC registration and GMC oversight.
GLP-1 Weight Management Programmes: Telehealth platforms offering semaglutide, tirzepatide, and other GLP-1 receptor agonist programmes for weight management. This category is evolving rapidly and the quality of platforms varies enormously. We evaluate clinical governance, compounding pharmacy practices (where applicable), pricing, and whether the programme includes the ongoing clinical monitoring that these medications require.
Online GP & Specialist Consultations: Digital platforms offering general and specialist consultations relevant to men’s urological and sexual health. We assess accessibility, consultation quality, follow-up processes, and whether the platform genuinely supplements NHS or private specialist care — or merely adds a step to the referral pathway.
Our Assessment Framework
Telehealth platform reviews follow a structured editorial assessment:
Clinical Governance: Who are the prescribers? What regulatory body oversees them? For UK platforms: is the service CQC-registered? Are prescribers GMC-registered? For international platforms: what is the equivalent regulatory framework?
Pricing Transparency: Is the full cost clear before the patient commits? Are there hidden consultation fees, mandatory blood testing charges, or subscription lock-ins? We report the actual all-in cost wherever possible.
UK Accessibility: Does the platform genuinely serve UK patients with UK-based prescribers and UK pharmacy fulfilment? Or is it a US platform that technically accepts UK addresses but ships from international pharmacies?
Clinical Appropriateness: Does the platform’s clinical model include appropriate screening, monitoring, and follow-up? Or does it prioritise speed and convenience over clinical thoroughness?
What We Do Not Do
We review telehealth platforms — we do not operate one. We do not book appointments, provide referrals, or facilitate access to any clinical service. If a platform review includes a link to the platform’s website, that link may be an affiliate link (disclosed clearly in the article). Clicking that link takes you to the platform’s own booking or information page — not to a service operated by or through this publication.
Read more about our editorial methodology and affiliate relationships on our Our Approach page.